Soleno Therapeutics Q2 EPS $(0.81) Up From $(0.90) YoY
Portfolio Pulse from Benzinga Newsdesk
Soleno Therapeutics reported Q2 losses of $(0.81) per share, a 10% improvement from $(0.90) per share losses in the same period last year.
August 08, 2023 | 9:59 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Soleno Therapeutics reported a 10% YoY improvement in Q2 losses, which may be seen positively by investors.
Soleno Therapeutics reported a 10% improvement in its Q2 losses compared to the same period last year. This indicates a positive trend in the company's financial performance, which could potentially lead to a positive impact on its stock price in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100